Martin Schroeder, MSC

Martin has over 25 years of successful experience in general management, technical R&D management, marketing, corporate finance and business development. Martin is a founder of Intercept Pharmaceuticals and has contributed to the success of companies such as @POS, Dow Chemical, Immunex, Medicine Planet, Cyrano Sciences, Gamera Bioscience, MetaXen, Vistagen, Bethesda Pharmaceuticals, Acacia Biosciences, Maxim Biotech, Invivogen, Optigon Technology, Primex Physics International and many others.

Patricia Reggio, PhD

Dr. Reggio is the Marie Foscue Rourk Professor of Chemistry & Biochemistry at UNC Greensboro with expertise in Computational Chemistry and Computer-Aided Drug Design. Her major focus has been on the G protein-coupled cannabinoid receptors, including CB1 and CB2. For years, her laboratory has collaborated with the NIH and NIDA and has gained significant insight into this area.

Rangan (Ronnie) Maitra, PhD

Dr. Maitra is a research pharmacologist at Research Triangle Institute and leads preclinical drug discovery research related to metabolic syndrome and liver disease. He is an expert in the mechanisms of chemotherapy-induced differential regulation of ABC transporters CFTR and P- glycoprotein, as well as preclinical drug discovery research related to endocannabinoid receptors.